Logos Global Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History
Bought
Maintained
Sold
Other funds holding LKFT
Logos Global Management's LKFT Position: Q4 2024 in Review
Logos Global Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2024, closing a stake of 800,000 shares — an estimated $23M sold.
Logos Global Management first reported a position in LKFT in Q1 2023 and held it in 3 quarters. The position peaked at $23M in Q3 2024. 81 funds tracked by Wall St. Rank hold LKFT as of Q4 2024.
- Logos Global Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2024 after selling out during the quarter.
- Logos Global Management sold 800,000 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2024, an estimated $23M.
- Logos Global Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2023 and held it in 3 quarters.
- Logos Global Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $23M in Q3 2024.
- 81 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2024.
Based on Logos Global Management's 13F filing for Q4 2024, filed 14 Feb 2025.